Literature DB >> 6146037

Role of a single haemopoietic growth factor in multiple proliferative disorders of haemopoietic and related cells.

J W Schrader.   

Abstract

Activated T cells secrete a glycoprotein (P-cell-stimulating factor; PSF) that stimulates the proliferation of many types of haemopoietic progenitor cells and the pluripotential haemopoietic stem cells. Based on experiments in mice, it is proposed that some proliferative disorders of the pluripotential haemopoietic stem cell or its progeny may result from the abnormal production and secretion of PSF by these cells themselves. The secreted PSF binding to specific receptors on the surface of these cells causes autostimulation and uncontrolled proliferation. Acute non-lymphocytic leukaemias and the late stages of Hodgkin's disease might be due to such autostimulation. More chronic proliferative diseases (eg, chronic myeloid leukaemia and the early stages of Hodgkin's disease) may involve the expansion of an abnormal, immortalised, clone of pluripotential haemopoietic stem cells or committed haemopoietic progenitor cells that are not autonomous but remain strictly dependent for their proliferation and survival on the presence of exogenous PSF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146037     DOI: 10.1016/s0140-6736(84)91049-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Refractory anaemia terminating in a combined lymphoproliferative and myeloproliferative disorder.

Authors:  L Camba; M V Joyner
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

Review 2.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

3.  A new approach to the evolution of the blastic crisis from chronic myelocytic leukemia: dynamic interplay of cellular alterations and a changing microenvironment.

Authors:  Z Grossman
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

4.  Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.

Authors:  Naoki Mizutani; Hiromi Ito; Kazumi Hagiwara; Misa Kobayashi; Asuka Hoshikawa; Yayoi Nishida; Akira Takagi; Tetsuhito Kojima; Motoshi Suzuki; Yosuke Osawa; Kazunori Ohnishi; Masanori Daibata; Takashi Murate
Journal:  Nagoya J Med Sci       Date:  2012-08       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.